SCHEMBL8548462

SCHEMBL8548462

Cc1c(OCCOCc2ccccc2)ccnc1CSc1nc2ccccc2[nH]1

nearest known ligand 0.66

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 5/20 0.66
NPC1 O15118 5/20 0.66
CYP2C9 P11712 5/20 0.66
CYP2D6 P10635 3/20 0.66
CYP2C19 P33261 3/20 0.66
CYP1A2 P05177 2/20 0.66
CYP3A4 P08684 2/20 0.66
AR P10275 5/20 0.48
KMT2A Q03164 4/20 0.47
LMNA P02545 4/20 0.47
MAPT P10636 3/20 0.47
HTT P42858 2/20 0.47
MEN1 O00255 2/20 0.47
GALR3 O60755 1/20 0.47
STAT3 P40763 1/20 0.47
NOS3 P29474 1/20 0.46
NOS1 P29475 1/20 0.46
NOS2 P35228 1/20 0.46
SMN1; SMN2 Q16637 4/20 0.45
TP53 P04637 2/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31515434 0.92 CYP2C9 (0.74) RAB9ANPC1CYP2C9CYP2D6CYP2C19
SCHEMBL10922316 0.91 RAB9A (0.72) RAB9ANPC1CYP2C9CYP2D6CYP2C19
SCHEMBL9025242 0.89 CYP2C9 (0.70) RAB9ANPC1CYP2C9CYP2D6CYP2C19
SCHEMBL8502993 0.89 CYP2C9 (0.64) RAB9ANPC1CYP2C9CYP2D6CYP2C19
SCHEMBL8502122 0.88 RAB9A (0.71) RAB9ANPC1CYP2C9CYP2D6CYP2C19
SCHEMBL8501939 0.88 RAB9A (0.68) RAB9ANPC1CYP2C9CYP2D6CYP2C19
SCHEMBL8500695 0.88 NPC1 (0.71) RAB9ANPC1CYP2C9CYP2D6CYP2C19
SCHEMBL8500352 0.87 CYP2C9 (0.67) RAB9ANPC1CYP2C9CYP2D6CYP2C19
SCHEMBL8501937 0.87 CYP2C9 (0.67) RAB9ANPC1CYP2C9CYP2D6CYP2C19
SCHEMBL8503083 0.87 NPC1 (0.51) RAB9ANPC1CYP2C9CYP2D6CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5840910-A Pyridine derivatives having anti-ulcerative activity ESAI CO., LTD. (JP) 1998-11-24 US disclosed
EP-0475456-B1 Pyridine derivatives, pharmaceutical compositions comprising the same, the use of the same for the manufacture of medicaments having therapeutic or preventative value, and a process for preparing the same EISAI CO LTD (JP) 1998-02-04 EP disclosed
EP-0786461-A1 Pyridine derivatives, pharmaceutical compositions comprising the same, the use of the same for the manufacture of medicaments having therapeutic or preventative value, and a process for preparing the same Eisai Co., Ltd. (JP) 1997-07-30 EP disclosed
EP-0654471-A1 Pyridine derivatives, pharmaceutical compositions comprising the same, the use of the same for the manufacture of medicaments having therapeutic or preventative value, and process for preparing the same Eisai Co., Ltd. (JP) 1995-05-24 EP disclosed
EP-0475456-A1 Pyridine derivatives, pharmaceutical compositions comprising the same, the use of the same for the manufacture of medicaments having therapeutic or preventative value, and a process for preparing the same Eisai Co., Ltd. (JP) 1992-03-18 EP disclosed
US-5045552-A Pyridine derivatives having anti-ulcerative activity EISAI CO., LTD. (JP) 1991-09-03 US disclosed